Compare · CNMD vs MASI
CNMD vs MASI
Side-by-side comparison of CONMED Corporation (CNMD) and Masimo Corporation (MASI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CNMD and MASI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
- MASI is the larger of the two at $9.42B, about 7.2x CNMD ($1.30B).
- CNMD has been more active in the news (9 items in the past 4 weeks vs 1 for MASI).
- MASI has more recent analyst coverage (24 ratings vs 16 for CNMD).
- Company
- CONMED Corporation
- Masimo Corporation
- Price
- -
- -
- Market cap
- $1.30B
- $9.42B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Exchange
- NYSE
- NASDAQ
- IPO
- 1987
- 2007
- News (4w)
- 9
- 1
- Recent ratings
- 16
- 24
CONMED Corporation
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
Masimo Corporation
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
Latest CNMD
- SEC Form 4 filed by Executive Vice President & CFO Gallagher John E
- New insider Gallagher John E claimed no ownership of stock in the company (SEC Form 3)
- BMO Capital Markets initiated coverage on CONMED with a new price target
- SEC Form 4 filed by Director Martin Celine Christine
- SEC Form 4 filed by Director Mirviss Jeffrey B.
- New insider Mirviss Jeffrey B. claimed no ownership of stock in the company (SEC Form 3)
- New insider Martin Celine Christine claimed no ownership of stock in the company (SEC Form 3)
- CONMED Corporation to Report Second Quarter 2026 Financial Results on July 29, 2026
- CONMED downgraded by BofA Securities with a new price target
- CONMED Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure
Latest MASI
- SEC Form 15-12G filed by Masimo Corporation
- Director Solomon Darlene J. S. returned $542,700 worth of shares to the company (3,015 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Scannell Timothy J returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- Director Lane Wendy E returned $469,440 worth of shares to the company (2,608 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Director by deputization Politan Capital Management Lp
- Director by deputization Politan Capital Management Lp returned $826,357,140 worth of shares to the company (4,590,873 units at $180.00) (SEC Form 4)
- Chairman of the Board Brennan Michelle returned $1,675,620 worth of shares to the company (9,309 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- SVP, Chief Accounting Officer Hataishi Paul returned $2,397,060 worth of shares to the company (13,317 units at $180.00), closing all direct ownership in the company (SEC Form 4)
- EVP, Operations Sampath Anand returned $6,102,180 worth of shares to the company (33,901 units at $180.00), closing all direct ownership in the company (SEC Form 4) to cover taxes
- SEC Form 4 filed by Chief Commercial Officer Meehan Greg Allen (for tax liability)